Back |
home / stock / femy / femy message board
Subject | By | Source | When |
---|---|---|---|
Green start here! | budfoxfun | investorshub | 07/15/2021 2:13:08 PM |
$FEMY trading up almost 15% on 40% volume | BlazingStocks | investorshub | 07/13/2021 7:27:59 PM |
Nice push into power hour! | budfoxfun | investorshub | 07/13/2021 6:33:54 PM |
Great find on $FEMY... definitely shows a$ HUGE | BlazingStocks | investorshub | 07/13/2021 4:52:28 PM |
Check out the Form 4 filings for insider | ProfitScout | investorshub | 07/13/2021 2:59:30 PM |
Thanks for sharing that link to the $FEMY | BlazingStocks | investorshub | 07/12/2021 7:22:05 PM |
Looking for an update to get some more | BlazingStocks | investorshub | 07/12/2021 7:19:58 PM |
Be sure to check out the $FEMY company | ProfitScout | investorshub | 07/12/2021 3:40:39 PM |
Close to breaking out this week! | budfoxfun | investorshub | 07/12/2021 2:14:32 PM |
$FEMY ASK is very thin to $7.92... | BlazingStocks | investorshub | 07/12/2021 2:10:09 PM |
Thin to 8's! | budfoxfun | investorshub | 07/09/2021 7:43:39 PM |
$FEMY $7.71 looking good, with a nice BID | BlazingStocks | investorshub | 07/09/2021 4:30:31 PM |
Wow 7.71's super thin! | budfoxfun | investorshub | 07/09/2021 3:42:51 PM |
Agreed...if $FEMY can hold $7 and build upon | BlazingStocks | investorshub | 07/09/2021 3:39:38 PM |
News, Short Squeeze, Breakout and More Instantly...
ATLANTA, June 27, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces it will be partici...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 3.5% to $130.78 on volume of 504,910,586 shares Nikola Corporation (NKLA) fell 31.5% to $0.3296 on volume of 265,124,783 shares SMX (Security Matters) Public Limited Company (SMX) rose 35.1% to $0.1608 o...
ATLANTA, June 20, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces it has received it...